Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients

• প্রধান লেখক: Daan W. Huntjens (Author), Jacob A. Dijkstra (Author), Lisanne N. Verwiel (Author), Mirjam Slijkhuis (Author), Paul Elbers (Author), Matthijs R. A. Welkers (Author), Agnes I. Veldkamp (Author), Marianne A. Kuijvenhoven (Author), David C. de Leeuw (Author), Heshu Abdullah-Koolmees (Author), Maria T. Kuipers (Author), Imke H. Bartelink (Author)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: MDPI AG, 2023-01-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Herpes simplex virus (HSV) and cytomegalovirus (CMV) are DNA viruses that are common among humans. Severely immunocompromised patients are at increased risk of developing HSV or CMV disease due to a weakened immune system. Antiviral therapy can be challenging because these drugs have a narrow therap...